Literature DB >> 7373220

Lymphocyte cooperation is required for amplification of macrophage procoagulant activity.

G A Levy, T S Edgington.   

Abstract

Murine splenic lymphoid cells have been shown to possess basal procoagulant activity. This activity was localized to most macrophages by assay of cell populations, as well as by a direct plaque assay that permitted identification of expressed procoagulant activity of individual viable cells as well as content. Both content and viable expression of procoagulant activity was markedly increased by exposure to bacterial lipopolysaccharide, reaching a maximum after 6 h. The quantitative increase in procoagulant activity content and viable expression was limited to the macrophage population. Separated populations of lymphocytes or macrophages could not be stimulated by lipopolysaccharide to increase procoagulant activity, whereas the addition of lymphocytes to macrophages at a 3-4:1 ratio maximally reconstituted the amplification of procoagulant activity. Further evidence of cellular collaboration followed from observation that only lymphocytes that had been exposed to lipopolysaccharide were capable of triggering the increase in macrophage procoagulant activity. This appears to represent a new form of lymphocyte-macrophage cooperation in an effector pathway that may participate in some forms of immunologic responses and contribute to the phenotypic features of certain immunologic tissue lesions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7373220      PMCID: PMC2185847          DOI: 10.1084/jem.151.5.1232

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

Review 1.  The tissue factor pathway of blood coagulation.

Authors:  Y Nemerson; F A Pitlick
Journal:  Prog Hemost Thromb       Date:  1972

2.  Tissue factor activity of normal and leukemic cells.

Authors:  S K Garg; J Niemetz
Journal:  Blood       Date:  1973-11       Impact factor: 22.113

3.  Studies on cell adhesion. II. Adhesion of cells to surfaces of diverse chemical composition and inhibition of adhesion by sulfhydryl binding reagents.

Authors:  F Grinnell; M Milam; P A Srere
Journal:  Arch Biochem Biophys       Date:  1972-11       Impact factor: 4.013

4.  The effect of carrageenan on delayed hypersensitivity reactions.

Authors:  H J Schwartz; S Leskowitz
Journal:  J Immunol       Date:  1969-07       Impact factor: 5.422

5.  Esterases in human leukocytes.

Authors:  C Y Li; K W Lam; L T Yam
Journal:  J Histochem Cytochem       Date:  1973-01       Impact factor: 2.479

6.  Role of leukocytes in blood coagulation and the generalized Shwartzman reaction.

Authors:  J Niemetz; K Fani
Journal:  Nat New Biol       Date:  1971-08-25

7.  Stimulation of human leukocyte thromboplastic activity by endotoxin.

Authors:  R G Lerner; R Goldstein; G Cummings; K Lange
Journal:  Proc Soc Exp Biol Med       Date:  1971-10

8.  Effect of anticoagulants on delayed hypersensitivity reactions.

Authors:  S Cohen; B Benacerraf; R T McCluskey; Z Ovary
Journal:  J Immunol       Date:  1967-02       Impact factor: 5.422

9.  Effect of alkali-treated lipopolysaccharide on erythrocyte membrane stability.

Authors:  I Ciznár; J W Shands
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

10.  Tissue factor activity in lymphocyte cultures from normal individuals and patients with hemophilia A.

Authors:  F R Rickles; J A Hardin; F A Pitlick; L W Hoyer; M E Conrad
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

View more
  49 in total

1.  Platelet-activating factor modulates endotoxin-induced macrophage procoagulant activity by a protein kinase C-dependent mechanism.

Authors:  D S Kucey; P Y Cheung; O D Rotstein
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity.

Authors:  S T Smiley; S N Boyer; M J Heeb; J H Griffin; M J Grusby
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid.

Authors:  R Lorenzet; J Niemetz; A J Marcus; M J Broekman
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

4.  The participation of macrophages, glomerular procoagulant activity, and factor VIII in glomerular fibrin deposition. Studies on anti-GBM antibody-induced glomerulonephritis in rabbits.

Authors:  P G Tipping; S R Holdsworth
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

5.  Absence of monocyte procoagulant activity during the immune response to influenza virus.

Authors:  M Mathies; N Hogg
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

6.  Expression of macrophage procoagulant activity in murine systemic lupus erythematosus.

Authors:  E H Cole; J Sweet; G A Levy
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

7.  16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.

Authors:  M Abecassis; J A Falk; L Makowka; V J Dindzans; R E Falk; G A Levy
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

8.  Tissue factor activity. A marker of alveolar macrophage maturation in rabbits. Effects of granulomatous pneumonitis.

Authors:  H Rothberger; M P McGee; T K Lee
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

9.  The comparative effects of cyclosporin A and 16,16 dimethyl prostaglandin E2 on the allogeneic induction of monocyte/macrophage procoagulant activity and the cytokines macrophage procoagulant inducing factor and interleukin-2.

Authors:  S W Chung; P C Kim; I H Koh; L S Fung; E H Cole; Z Cohen; G A Levy
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

10.  Is lymphocyte co-operation necessary for thromboplastin synthesis by human monocytes?

Authors:  T Lyberg; H Prydz
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.